These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 30720033)
21. Identification of transcriptional isoforms associated with survival in cancer patient. Tang Z; Chen T; Ren X; Zhang Z J Genet Genomics; 2019 Sep; 46(9):413-421. PubMed ID: 31630971 [TBL] [Abstract][Full Text] [Related]
22. Revisiting the identification of canonical splice isoforms through integration of functional genomics and proteomics evidence. Li HD; Menon R; Omenn GS; Guan Y Proteomics; 2014 Dec; 14(23-24):2709-18. PubMed ID: 25265570 [TBL] [Abstract][Full Text] [Related]
23. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers. Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135 [TBL] [Abstract][Full Text] [Related]
24. The prognostic potential of alternative transcript isoforms across human tumors. Trincado JL; Sebestyén E; Pagés A; Eyras E Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130 [TBL] [Abstract][Full Text] [Related]
25. Alternative Splicing May Not Be the Key to Proteome Complexity. Tress ML; Abascal F; Valencia A Trends Biochem Sci; 2017 Feb; 42(2):98-110. PubMed ID: 27712956 [TBL] [Abstract][Full Text] [Related]
26. Multiple breast cancer risk variants are associated with differential transcript isoform expression in tumors. Caswell JL; Camarda R; Zhou AY; Huntsman S; Hu D; Brenner SE; Zaitlen N; Goga A; Ziv E Hum Mol Genet; 2015 Dec; 24(25):7421-31. PubMed ID: 26472073 [TBL] [Abstract][Full Text] [Related]
27. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Campbell-Thompson M; Lynch IJ; Bhardwaj B Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261 [TBL] [Abstract][Full Text] [Related]
28. Exploiting single-cell RNA sequencing data to link alternative splicing and cancer heterogeneity: A computational approach. Manipur I; Granata I; Guarracino MR Int J Biochem Cell Biol; 2019 Mar; 108():51-60. PubMed ID: 30633986 [TBL] [Abstract][Full Text] [Related]
29. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer. Vu TN; Pramana S; Calza S; Suo C; Lee D; Pawitan Y Oncotarget; 2016 Oct; 7(42):68851-68863. PubMed ID: 27634900 [TBL] [Abstract][Full Text] [Related]
31. ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer. Yang IS; Son H; Kim S; Kim S BMC Genomics; 2016 Aug; 17(1):631. PubMed ID: 27519173 [TBL] [Abstract][Full Text] [Related]
33. Alternative splicing variant of RHBDD2 is associated with cell stress response and breast cancer progression. Canzoneri R; Rabassa ME; Gurruchaga A; Ferretti V; Palma S; Isla-Larrain M; Croce MV; Lacunza E; Abba MC Oncol Rep; 2018 Aug; 40(2):909-915. PubMed ID: 29901166 [TBL] [Abstract][Full Text] [Related]
34. Expression profile analyses of human HCT-116 colon cancer cell line before and after serum induction. Yin H; Yan Z; Liang Y; Liu B; Su Q Gene; 2013 Apr; 517(2):236-9. PubMed ID: 23266807 [TBL] [Abstract][Full Text] [Related]
36. Relative expression of hMena11a and hMenaINV splice isoforms is a useful biomarker in development and progression of human breast carcinoma. Tanaka N; Yoshida H; Suzuki Y; Harigaya K Int J Oncol; 2014 Nov; 45(5):1921-8. PubMed ID: 25109497 [TBL] [Abstract][Full Text] [Related]
37. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Calin GA; di Iasio MG; Caprini E; Vorechovsky I; Natali PG; Sozzi G; Croce CM; Barbanti-Brodano G; Russo G; Negrini M Oncogene; 2000 Feb; 19(9):1191-5. PubMed ID: 10713707 [TBL] [Abstract][Full Text] [Related]
38. Identification and quantification of osteopontin splice variants in the plasma of lung cancer patients using immunoaffinity capture and targeted mass spectrometry. Wu J; Pungaliya P; Kraynov E; Bates B Biomarkers; 2012 Mar; 17(2):125-33. PubMed ID: 22188260 [TBL] [Abstract][Full Text] [Related]
39. RPS24 alternative splicing is a marker of cancer progression and epithelial-mesenchymal transition. Park J; Nam DH; Kim D; Chung YJ Sci Rep; 2024 Jun; 14(1):13246. PubMed ID: 38853173 [TBL] [Abstract][Full Text] [Related]
40. Thymopoietin Beta and Gamma Isoforms as a Potential Diagnostic Molecular Marker for Breast Cancer: Preliminary Data. Marrero-Rodríguez D; Taniguchi-Ponciano K; Lopez-Sleman J; Romero-Morelos P; Mendoza-Rodríguez M; Garcia I; Huerta-Padilla V; Mantilla A; Duarte A; Piña P; Rodriguez-Esquivel M; Lopez-Romero R; Parrazal-Romero J; Tobias-Alonso S; Jimenez-Vega F; Alvarez-Blanco M; Salcedo M Pathol Oncol Res; 2015 Sep; 21(4):1045-50. PubMed ID: 25837847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]